Charles S Fermaintt

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 6

Top Topics

Mitochondrial Dna

Metastatic Breast Cancer

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Leila Takahashi-Ruiz, Charles S Fermaintt, Nancy J Wilkinson, Peter Y W Chan, Susan L Mooberry, April L Risinger
The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models. Cancers 14 (23) (2022)
Leila Takahashi-Ruiz, Charles S Fermaintt, Nancy J Wilkinson, Peter Y W Chan, Susan L Mooberry, April L Risinger
The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models. Cancers 14 (23) (2022)
Leila Takahashi-Ruiz, Charles S Fermaintt, Nancy J Wilkinson, Peter Y W Chan, Susan L Mooberry, April L Risinger
The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models. Cancers 14 (23) (2022)
Leila Takahashi-Ruiz, Charles S Fermaintt, Nancy J Wilkinson, Peter Y W Chan, Susan L Mooberry, April L Risinger
The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models. Cancers 14 (23) (2022)
Susan Matthew, Qi-Yin Chen, Ranjala Ratnayake, Charles S Fermaintt, Daniel Lucena-Agell, Francesca Bonato, Andrea E Prota, Seok Ting Lim, Xiaomeng Wang, José Fernando Díaz, April L Risinger, Valerie J Paul, María Ángela Oliva, Hendrik Luesch
Gatorbulin-1, a distinct cyclodepsipeptide chemotype, targets a seventh tubulin pharmacological site. Proceedings of the National Academy of Sciences of the United States of America 118 (9) (2021)
Charles S Fermaintt, Thilini Peramuna, Shengxin Cai, Leila Takahashi-Ruiz, Jacob Nathaniel Essif, Corena V Grant, Barry R Oâ Keefe, Susan L Mooberry, Robert H Cichewicz, April L Risinger
Yuanhuacine Is a Potent and Selective Inhibitor of the Basal-Like 2 Subtype of Triple Negative Breast Cancer with Immunogenic Potential. Cancers 13 (11) (2021)